Author: Yang, Hang; Zhao, Xiaohui; Xun, Meng; Xu, Lingjie; Liu, Bing; Wang, Hongliang
                    Title: Cytoplasmic domain and enzymatic activity of ACE2 is not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells  Cord-id: baqjwq6l  Document date: 2021_3_2
                    ID: baqjwq6l
                    
                    Snippet: The recent COVID-19 pandemic poses a global health emergency. Cellular entry of the causative agent SARS-CoV-2 is mediated by its spike protein interacting with cellular receptor- human angiotensin converting enzyme 2 (ACE2). Here, we used lentivirus based pseudotypes bearing spike protein to demonstrate that entry of SARS-CoV-2 into host cells is dependent on clathrin-mediated endocytosis, and phosphoinositides play essential role during this process. In addition, we showed that the intracellul
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: The recent COVID-19 pandemic poses a global health emergency. Cellular entry of the causative agent SARS-CoV-2 is mediated by its spike protein interacting with cellular receptor- human angiotensin converting enzyme 2 (ACE2). Here, we used lentivirus based pseudotypes bearing spike protein to demonstrate that entry of SARS-CoV-2 into host cells is dependent on clathrin-mediated endocytosis, and phosphoinositides play essential role during this process. In addition, we showed that the intracellular domain and the catalytic activity of ACE2 is not required for efficient virus entry. These results provide new insights into SARS-CoV-2 cellular entry and present potential targets for drug development.
 
  Search related documents: 
                                Co phrase  search for related documents- acute sars cov respiratory syndrome coronavirus and luciferase assay system: 1
  - acute sars cov respiratory syndrome coronavirus and lysosomotropic agent: 1, 2, 3, 4, 5
  - luciferase activity and madison wi: 1, 2, 3, 4, 5
  - luciferase activity and madison wi promega: 1, 2, 3, 4, 5
  - luciferase activity and madison wi promega luciferase assay system: 1
  - luciferase assay system and madison wi: 1, 2, 3
  - luciferase assay system and madison wi promega: 1, 2, 3
  - luciferase assay system and madison wi promega luciferase assay system: 1, 2, 3
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date